Shortage reports
Actual shortage:
283 (9%)
Anticipated shortage:
1 (0%)
Avoided shortage:
10 (0%)
Resolved:
2953 (91%)
3247
Discontinuation Reports
To be discontinued:
2 (0%)
Discontinued:
410 (94%)
Reversed:
23 (5%)
435
483 (13%)
16 (6%)
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| ACT BORTEZOMIB | 3.5MG | POWDER FOR SOLUTION | Resolved | 2020-01-30 | 2020-05-29 | 104930 |
| ACT BORTEZOMIB | 3.5MG | POWDER FOR SOLUTION | Actual shortage | 2025-01-23 | 2025-01-23 | 248442 |
| ACT BUPRENORPHINE/NALOXONE | 8MG 2MG | TABLET | Resolved | 2019-09-26 | 2020-01-24 | 94896 |
| ACT BUPRENORPHINE/NALOXONE | 2MG 0.5MG | TABLET | Resolved | 2019-10-03 | 2020-01-24 | 95396 |
| ACT BUPROPION XL | 300MG | TABLET (EXTENDED-RELEASE) | Resolved | 2020-04-23 | 2020-05-08 | 113043 |
| ACT BUPROPION XL | 300MG | TABLET (EXTENDED-RELEASE) | Resolved | 2020-04-03 | 2020-05-08 | 110797 |
| ACT BUPROPION XL | 300MG | TABLET (EXTENDED-RELEASE) | Resolved | 2018-12-04 | 2020-02-13 | 68577 |
| ACT BUPROPION XL | 300MG | TABLET (EXTENDED-RELEASE) | Resolved | 2020-06-25 | 2021-04-29 | 118960 |
| ACT BUPROPION XL | 150MG | TABLET (EXTENDED-RELEASE) | Resolved | 2020-05-01 | 2020-05-08 | 113726 |
| ACT BUPROPION XL | 150MG | TABLET (EXTENDED-RELEASE) | Resolved | 2018-12-04 | 2019-10-17 | 68569 |
| ACT BUPROPION XL | 150MG | TABLET (EXTENDED-RELEASE) | Resolved | 2018-12-04 | 2019-10-10 | 68572 |
| ACT BUPROPION XL | 300MG | TABLET (EXTENDED-RELEASE) | Resolved | 2018-12-04 | 2019-11-22 | 68580 |
| ACT CABERGOLINE | 0.5MG | TABLET | Actual shortage | 2017-05-03 | 2017-10-05 | 8767 |
| ACT CELECOXIB | 100MG | CAPSULE | Resolved | 2021-01-28 | 2021-02-12 | 132669 |
| ACT CELECOXIB | 100MG | CAPSULE | Resolved | 2017-03-17 | 2018-10-11 | 3390 |
| ACT CELECOXIB | 100MG | CAPSULE | Resolved | 2019-08-22 | 2020-03-12 | 92235 |
| ACT CELECOXIB | 100MG | CAPSULE | Resolved | 2021-01-22 | 2021-02-12 | 132297 |
| ACT CELECOXIB | 100MG | CAPSULE | Resolved | 2019-08-22 | 2021-02-12 | 92232 |
| ACT CELECOXIB | 200MG | CAPSULE | Resolved | 2018-12-04 | 2019-08-06 | 68586 |
| ACT CELECOXIB | 200MG | CAPSULE | Resolved | 2018-12-04 | 2019-04-11 | 68583 |
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-TRIAMTERENE/HCTZ | 25MG 50MG | TABLET | Discontinued | 2017-06-27 | 2017-06-27 | 14060 |
| TEVA-TRIAMTERENE/HCTZ | 50MG 25MG | TABLET | Discontinued | 2020-05-14 | 2020-05-14 | 115091 |
| TEVA-TRIMEL | 400MG 80MG | TABLET | Discontinued | 2020-02-13 | 2020-02-13 | 106133 |
| TEVA-TRIMEL | 400MG 80MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 65017 |
| TEVA-TRIMEL DS | 800MG 160MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 65020 |
| TEVA-TRIMEL DS | 800MG 160MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 65023 |
| TEVA-TRYPTOPHAN | 500MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258565 |
| TEVA-TRYPTOPHAN | 1G | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258616 |
| TEVA-TRYPTOPHAN | 500MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258619 |
| TEVA-TRYPTOPHAN | 500MG | TABLET | Discontinued | 2025-06-17 | 2025-06-17 | 260534 |
| TEVA-VALGANCICLOVIR | 450MG | TABLET | Reversed | 2025-05-28 | 2025-06-04 | 258577 |
| TEVA-VALGANCICLOVIR | 450MG | TABLET | Reversed | 2025-05-28 | 2025-06-04 | 258768 |
| TEVA-VALGANCICLOVIR | 450MG | TABLET | Reversed | 2025-05-28 | 2025-06-04 | 258783 |
| TEVA-VALSARTAN | 80MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258496 |
| TEVA-VALSARTAN | 40MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258501 |
| TEVA-VALSARTAN | 320MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258484 |
| TEVA-VALSARTAN | 160MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258490 |
| TEVA-VALSARTAN | 160MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256152 |
| TEVA-VALSARTAN | 320MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256155 |
| TEVA-VALSARTAN | 40MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256146 |